Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

NCT00002849

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 40 locations
View Trial Details
Completed

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

NCT01120457

Conditions
Acute Myelogenous Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Uab Comprehensive Cancer Center Birmingham, Alabama, United States
  • Uc San Diego Moores Cancer Center La Jolla, California, United States
  • Usc - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Ucla-Division Of Hematology/Oncology Los Angeles, California, United States
View Trial Details
Completed

Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

NCT00042354

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +3 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles, California, United States
  • Children's Hospital Orange County, California, United States
  • Children's Hospital San Diego, California, United States
View all 18 locations
View Trial Details
Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • Novartis Investigative Site Cardiff, Wales, United Kingdom
  • Novartis Investigative Site Bournemouth, United Kingdom
  • Novartis Investigative Site East Yorkshire, United Kingdom
  • Novartis Investigative Site Edinburgh, United Kingdom
View Trial Details

Related conditions